Komen Race for the Cure

The Susan G. Komen Race for the Cure® Series, the largest series of 5K runs/fitness walks in the world, raises significant funds and awareness for the fight against breast cancer, celebrates breast cancer survivorship and honors those who have lost their battle with the disease. Since its inception in 1983, the Komen Race for the Cure series has grown from one local Race with 800 participants to a global series of more than 120 Races with millions of people participating.

IMAGINE THE IMPACT

How does a 5K Race make a huge impact on the global movement to end breast cancer forever?  Through the fundraising efforts of every participant.  You don’t need to be a fundraising expert to be successful at it – you just need the desire to stand up to breast cancer and make a difference.  Thanks to people like you, the Peoria Memorial Affiliate of Susan G. Komen for the Cure® has awarded more than $7 million to Central Illinois agencies for breast health awareness, education, screening, and treatment. This year we’re aiming even higher!  If every Race participant raised an average of $100 over the registration fee, the Komen Peoria Affiliate would raise an additional $1.9 million.  Together, we can save lives!

Why we need your support:

Every step counts! Your donation provides women and men in Peoria with services that have literally saved lives. You help make the following programs possible:

• Free mammograms and diagnostics
• Medical treatment for qualified breast cancer patients who cannot afford care, including surgery, chemotherapy, and radiation
• Support services including support groups, assistance with finding financial resources, prescription refills and transportation to medical appointments
• Education about the warning signs of breast cancer, methods of early detection and the latest treatment options
• Cutting edge research to find a cure for breast cancer

Up to 75 percent of net proceeds are used for local programs like those listed above, with 25 percent used to fund breast cancer research.